CD4 and metabolic dysfunction-associated steatohepatitis: Nevertheless, recent studies in mice and few data from humans indicate a decisive role of CD4+ T cells in the progression from NAFLD to NASH up to HCC development (Hammerich et al., 2011; Rau et al., 2016).